Anheuser-Busch InBev SA/NV (NYSE:BUD) Shares Acquired by Central Pacific Bank Trust Division

Central Pacific Bank Trust Division raised its stake in Anheuser-Busch InBev SA/NV (NYSE:BUD) by 27.7% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 13,150 shares of the consumer goods maker’s stock after buying an additional 2,850 shares during the period. Central Pacific Bank Trust Division’s holdings in Anheuser-Busch InBev SA/NV were worth $658,000 as of its most recent filing with the SEC.

Several other large investors have also modified their holdings of the stock. Holocene Advisors LP raised its holdings in Anheuser-Busch InBev SA/NV by 22.8% during the 3rd quarter. Holocene Advisors LP now owns 4,331,636 shares of the consumer goods maker’s stock worth $287,144,000 after buying an additional 803,257 shares during the period. Fisher Asset Management LLC grew its holdings in shares of Anheuser-Busch InBev SA/NV by 6.0% during the third quarter. Fisher Asset Management LLC now owns 10,307,014 shares of the consumer goods maker’s stock valued at $683,252,000 after buying an additional 587,329 shares in the last quarter. Renaissance Technologies LLC lifted its stake in Anheuser-Busch InBev SA/NV by 672.3% in the 2nd quarter. Renaissance Technologies LLC now owns 600,300 shares of the consumer goods maker’s stock worth $34,907,000 after acquiring an additional 522,575 shares in the last quarter. International Assets Investment Management LLC acquired a new position in shares of Anheuser-Busch InBev SA/NV in the 3rd quarter valued at about $154,640,000. Finally, GFS Advisors LLC boosted its holdings in shares of Anheuser-Busch InBev SA/NV by 56,727.5% during the third quarter. GFS Advisors LLC now owns 196,055 shares of the consumer goods maker’s stock worth $12,996,000 after purchasing an additional 195,710 shares during the period. 5.53% of the stock is owned by institutional investors.

Anheuser-Busch InBev SA/NV Price Performance

Shares of NYSE:BUD opened at $48.85 on Friday. The company has a debt-to-equity ratio of 0.85, a current ratio of 0.69 and a quick ratio of 0.51. The stock has a market capitalization of $87.79 billion, a P/E ratio of 15.08, a P/E/G ratio of 1.68 and a beta of 1.08. The business has a 50-day moving average of $54.65 and a two-hundred day moving average of $59.51. Anheuser-Busch InBev SA/NV has a fifty-two week low of $48.55 and a fifty-two week high of $67.49.

Wall Street Analyst Weigh In

BUD has been the subject of a number of research analyst reports. TD Cowen downgraded shares of Anheuser-Busch InBev SA/NV from a “buy” rating to a “hold” rating and increased their target price for the stock from $68.00 to $88.00 in a research report on Tuesday, October 8th. Evercore ISI raised Anheuser-Busch InBev SA/NV to a “strong-buy” rating in a research report on Monday, September 30th. Morgan Stanley boosted their target price on Anheuser-Busch InBev SA/NV from $68.50 to $73.00 and gave the company an “overweight” rating in a research note on Tuesday, September 10th. Citigroup raised Anheuser-Busch InBev SA/NV from a “neutral” rating to a “buy” rating in a research note on Tuesday, October 1st. Finally, Barclays raised Anheuser-Busch InBev SA/NV to a “strong-buy” rating in a research note on Wednesday, October 9th. Two equities research analysts have rated the stock with a hold rating, four have given a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, Anheuser-Busch InBev SA/NV currently has a consensus rating of “Buy” and a consensus price target of $79.00.

About Anheuser-Busch InBev SA/NV

Anheuser-Busch InBev SA/NV produces, distributes, exports, markets, and sells beer and beverages. It offers a portfolio of approximately 500 beer brands, which primarily include Budweiser, Corona, and Stella Artois; Beck's, Hoegaarden, Leffe, and Michelob Ultra; and Aguila, Antarctica, Bud Light, Brahma, Cass, Castle, Castle Lite, Cristal, Harbin, Jupiler, Modelo Especial, Quilmes, Victoria, Sedrin, and Skol brands.